Cureus | A Rare Case of Dose-Dependent Losartan-Induced Angioedema | Article
A practical guide to antiproteinuric drugs in dogs
Adding ACE Inhibitors or ARBs to Standard Therapy for Stable Ischemic Heart Disease | AAFP
Frontiers | Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis | Heart
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology
NKF KDOQI Guidelines
Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic | European Medicines Agency
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? | Cardiovascular Diabetology | Full Text
Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection | BMJ Open
RACGP - ACEIs for cardiovascular risk reduction – have we taken our eye off the ball?
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | SpringerLink
JCM | Free Full-Text | Therapeutic Advances in Diabetic Nephropathy
The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases - Ranjbar - 2019 - Journal of Cellular Physiology - Wiley Online Library
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk | Hypertension
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
How effectively do ACE inhibitors and ARBs prevent migraines? | MDedge Family Medicine
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
